Search research articles
Contact Us
Filters
Showing results (21-30 of 88) with videos related to
Page
of 9
Sort By:
Annals of Laboratory Medicine
|
October 16, 2020
Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients
Ja Young Seo, Jeong-Yeal Ahn, Bhumsuk Keam, et al.
Oncotargets and Therapy
|
August 24, 2019
Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations
Ho Cheol Kim, Yeh Rim Kang, Wonjun Ji, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 12, 2022
Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinoma
Bokyung Ahn, Shinkyo Yoon, Deokhoon Kim, et al.
Cancer Research and Treatment
|
May 6, 2021
The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
Hyehyun Jeong, Kye Jin Park, Yongjune Lee, et al.
JAMA Network Open
|
March 24, 2021
Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
Hyo Jung Park, Kyung Won Kim, Sang Eun Won, et al.
Journal of Cancer Research and Clinical Oncology
|
June 25, 2016
Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer
Shinkyo Yoon, Byung Woog Kang, Su Yeon Park, et al.
Cancer Research and Treatment
|
March 28, 2019
Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients
Yeonjoo Choi, Bhumsuk Keam, Miso Kim, et al.
Cancer Research and Treatment
|
February 17, 2025
A Multicenter Phase II Study of Modified FOLFIRINOX for First-line Treatment for Advanced Urachal Cancer (ULTMA; KCSG GU20-03)
Inkeun Park, Jae Lyun Lee, Shinkyo Yoon, et al.
Korean Journal of Radiology
|
September 28, 2025
State-of-the-Art Imaging in Antibody-Drug Conjugate Treatment for Advanced Bladder Cancer
Sarah Eid, Abdullah S Al-Yousef, Kyung Won Kim, et al.
Translational Lung Cancer Research
|
July 23, 2021
Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study
Myeong Geun Choi, Chang-Min Choi, Dae Ho Lee, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 88) with videos related to
Sort By:
Page
of 9
Annals of Laboratory Medicine
|
October 16, 2020
Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients
Ja Young Seo, Jeong-Yeal Ahn, Bhumsuk Keam, et al.
Oncotargets and Therapy
|
August 24, 2019
Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations
Ho Cheol Kim, Yeh Rim Kang, Wonjun Ji, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 12, 2022
Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinoma
Bokyung Ahn, Shinkyo Yoon, Deokhoon Kim, et al.
Cancer Research and Treatment
|
May 6, 2021
The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
Hyehyun Jeong, Kye Jin Park, Yongjune Lee, et al.
JAMA Network Open
|
March 24, 2021
Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
Hyo Jung Park, Kyung Won Kim, Sang Eun Won, et al.
Journal of Cancer Research and Clinical Oncology
|
June 25, 2016
Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer
Shinkyo Yoon, Byung Woog Kang, Su Yeon Park, et al.
Cancer Research and Treatment
|
March 28, 2019
Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients
Yeonjoo Choi, Bhumsuk Keam, Miso Kim, et al.
Cancer Research and Treatment
|
February 17, 2025
A Multicenter Phase II Study of Modified FOLFIRINOX for First-line Treatment for Advanced Urachal Cancer (ULTMA; KCSG GU20-03)
Inkeun Park, Jae Lyun Lee, Shinkyo Yoon, et al.
Korean Journal of Radiology
|
September 28, 2025
State-of-the-Art Imaging in Antibody-Drug Conjugate Treatment for Advanced Bladder Cancer
Sarah Eid, Abdullah S Al-Yousef, Kyung Won Kim, et al.
Translational Lung Cancer Research
|
July 23, 2021
Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study
Myeong Geun Choi, Chang-Min Choi, Dae Ho Lee, et al.
Page
of 9